Phreesia Free Cash Flow 2019-2024 | PHR
Phreesia Annual Free Cash Flow | |
---|---|
2024 | -57.48 |
2023 | -116.33 |
2022 | -105.52 |
2021 | -15.69 |
2020 | -11.49 |
2019 | -11.96 |
2018 | -23.11 |
Phreesia Quarterly Free Cash Flow | |
---|---|
2024-10-31 | -0.91 |
2024-07-31 | -2.51 |
2024-04-30 | -6.17 |
2024-01-31 | -57.48 |
2023-10-31 | -46.53 |
2023-07-31 | -34.91 |
2023-04-30 | -19.74 |
2023-01-31 | -116.33 |
2022-10-31 | -93.83 |
2022-07-31 | -66.35 |
2022-04-30 | -40.66 |
2022-01-31 | -105.52 |
2021-10-31 | -61.29 |
2021-07-31 | -22.26 |
2021-04-30 | -12.37 |
2021-01-31 | -15.69 |
2020-10-31 | -12.29 |
2020-07-31 | -7.92 |
2020-04-30 | -1.17 |
2020-01-31 | -11.49 |
2019-10-31 | -9.60 |
2019-07-31 | -3.05 |
2019-04-30 | -0.69 |
2019-01-31 | |
2018-10-31 | -5.47 |
2018-07-31 | -3.92 |
2018-01-31 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $1.654B | $0.356B |
Phreesia Inc. provides a patient intake management platform. The company's SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia Inc. is based in New York. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Veeva Systems (VEEV) | United States | $37.870B | 55.80 |
Tempus AI (TEM) | United States | $9.036B | 0.00 |
Hims & Hers Health (HIMS) | United States | $8.145B | 207.11 |
Inspire Medical Systems (INSP) | United States | $5.799B | 180.84 |
IRhythm Technologies (IRTC) | United States | $3.407B | 0.00 |
Privia Health (PRVA) | United States | $2.742B | 228.50 |
Enovis (ENOV) | United States | $2.671B | 17.80 |
Azenta (AZTA) | United States | $2.470B | 131.83 |
Clover Health Investments (CLOV) | United States | $2.200B | 0.00 |
Omnicell (OMCL) | United States | $2.084B | 68.17 |
Schrodinger (SDGR) | United States | $1.827B | 0.00 |
10x Genomics (TXG) | United States | $1.816B | 0.00 |
Butterfly Network (BFLY) | United States | $0.850B | 0.00 |
Standard BioTools (LAB) | United States | $0.577B | 0.00 |
Talkspace (TALK) | United States | $0.524B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.509B | 0.00 |
TruBridge (TBRG) | United States | $0.370B | 107.91 |
Nyxoah SA (NYXH) | Belgium | $0.368B | 0.00 |
Health Catalyst (HCAT) | United States | $0.343B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.229B | 0.00 |
Pulmonx (LUNG) | United States | $0.224B | 0.00 |
American Well (AMWL) | United States | $0.165B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.090B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.087B | 0.00 |
P3 Health Partners (PIII) | United States | $0.065B | 0.00 |
HeartBeam (BEAT) | United States | $0.064B | 0.00 |
CareCloud (CCLD) | United States | $0.056B | 0.00 |
111 (YI) | China | $0.050B | 0.00 |
SHL Telemedicine (SHLT) | Israel | $0.047B | 0.00 |
Outset Medical (OM) | United States | $0.043B | 0.00 |
Zepp Health (ZEPP) | China | $0.042B | 0.00 |
Zhongchao (ZCMD) | China | $0.035B | 0.00 |
Movano (MOVE) | United States | $0.035B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.020B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.020B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.014B | 0.00 |
MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
Precipio (PRPO) | United States | $0.010B | 0.00 |
Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
Syra Health (SYRA) | United States | $0.004B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.004B | 0.00 |
HeartSciences (HSCS) | United States | $0.003B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
Future Health ESG (FHLT) | United States | $0.000B | 0.00 |